Veliparib in combination for treating BRCA-positive, HER2-negative breast advanced cancer [ID1404]

  • Discontinued
  • GID-TA10327

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators